Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator

被引:29
作者
Prudlo, J
Koenig, J
Gräser, J
Burckhardt, E
Mestres, P
Menger, M
Roemer, K
机构
[1] Univ Saarlandes, Abt Virol, D-66421 Homburg, Germany
[2] Univ Saarlandes, Neurol Klin, D-66421 Homburg, Germany
[3] Univ Saarlandes, Inst Med Biometrie Epidemiol & Med Informat, D-66421 Homburg, Germany
[4] Univ Saarlandes, Inst Anat, D-66421 Homburg, Germany
[5] Univ Saarlandes, Inst Klin Expt Chirurg, D-66421 Homburg, Germany
关键词
ALS; FALS; apoptosis; motor neuron disease; P53;
D O I
10.1016/S0006-8993(00)02745-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mutant Cu/Zn superoxide dismutase (SOD1) associated with familial amyotrophic lateral sclerosis (FALS) causes selective motor neuron loss through unknown mechanisms of cell damage. Damaged neurons frequently undergo apoptosis mediated by the p53 cell survival regulator. We therefore studied whether motor neuron disease (MND) in mice expressing the human SOD1 mutant G93A is dependent on p53 by crossing G93A mice with p53-knockout mice. Since p53-/- mice's life expectance is usually shorter (160+/-49 days, n=11) than the time at which the G93A mice die from MND (212+/-50 days, n=7), only a few of the G93A/p53-/- double transgenics were expected to live to experience MND. Nevertheless, four of the 22 G93A/p53-/- mice succumbed to MND after 160+/-28 days, as expected under these conditions of competing death risks if the absence of p53 fails to protect from MND. Thus, MND in mice expressing G93A does not require p53. This conclusion is supported by histology: pre-symptomatic G93A mice display disease-associated vacuoles within the dendrites of motor neurons regardless of p53 status. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 20 条
[1]   P53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors [J].
Aloyz, RS ;
Bamji, SX ;
Pozniak, CD ;
Toma, JG ;
Atwal, J ;
Kaplan, DR ;
Miller, FD .
JOURNAL OF CELL BIOLOGY, 1998, 143 (06) :1691-1703
[2]  
Anderson CNG, 1999, J NEUROSCI, V19, P664
[3]   The role of p53 in tumour suppression: lessons from mouse models [J].
Attardi, LD ;
Jacks, T .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :48-63
[4]   Mechanisms of p53-mediated apoptosis [J].
Bates, S ;
Vousden, KH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :28-37
[5]  
BLYTH K, 1995, ONCOGENE, V10, P1717
[6]   p53 in embryonic development: maintaining a fine balance [J].
Choi, J ;
Donehower, LA .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :38-47
[7]   THYMOCYTE APOPTOSIS INDUCED BY P53-DEPENDENT AND INDEPENDENT PATHWAYS [J].
CLARKE, AR ;
PURDIE, CA ;
HARRISON, DJ ;
MORRIS, RG ;
BIRD, CC ;
HOOPER, ML ;
WYLLIE, AH .
NATURE, 1993, 362 (6423) :849-852
[8]   From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS [J].
Cleveland, DW .
NEURON, 1999, 24 (03) :515-520
[9]  
DALCANTO MC, 1994, AM J PATHOL, V145, P1271
[10]   Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS [J].
Durham, HD ;
Roy, J ;
Dong, L ;
Figlewicz, DA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (05) :523-530